4.8 Article

Immunomodulation of Telmisartan-Loaded PCL/PVP Scaffolds on Macrophages Promotes Endogenous Bone Regeneration

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 14, Issue 14, Pages 15942-15955

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.1c24748

Keywords

telmisartan; electrospinning immunomodulation; macrophage polarization; osteogenesis

Funding

  1. Key Project of Science and Technology of Jiangsu Province [BE2018644]
  2. Science and Technology Support Plan of Changzhou city (Social Development) [CE20185047]
  3. Changzhou SciTech Program [CJ20210102]
  4. EPSRC [EP/N007174/1, EP/N023579/1]
  5. Jiangsu, a specially appointed professor program

Ask authors/readers for more resources

In this study, a nanostructured scaffold loaded with telmisartan was developed to modulate the immune response and promote bone healing. The results showed that telmisartan-loaded scaffolds exhibited anti-inflammatory activity and enhanced bone regeneration by regulating macrophage polarization.
Biomaterial-immune system interactions play an important role in postimplantation osseointegration to retain the functionality of healthy and intact bones. Therefore, appropriate osteoimmunomodulation of implants has been considered and validated as an efficient strategy to alleviate inflammation and enhance new bone formation. Here, we fabricated a nanostructured PCL/PVP (polycaprolactone/polyvinylpyrrolidone) electrospinning scaffold for cell adhesion, tissue ingrowth, and bone defect padding. In addition, telmisartan, an angiotensin 2 receptor blocker with distinct immune bioactivity, was doped into PCL-/PVP-electrospun scaffolds at different proportions [1% (TPP-1), 5% (TPP-5), and 10% (TPP-10)] to investigate its immunomodulatory effects and osteoinductivity/conductivity. Telmisartan-loaded scaffolds displayed in vitro anti-inflammatory bioactivity on lipopolysaccharide-induced M1 macrophages by polarizing them to an M2-like phenotype and exhibited pro-osteogenic properties on bone marrow-derived mesenchymal stem cells (BMSCs). Histological analysis and micro-CT results of a rat skull defect model also showed that the telmisartan-loaded scaffolds induced a higher M2/M1 ratio, less inflammatory infiltration, and better bone regenerative patterns. Furthermore, activation of the BMP2 (bone morphogenetic protein-2)-Smad signaling pathway was found to be dominant in telmisartan-loaded scaffold-mediated macrophage-BMSC interactions. These findings indicate that telmisartan incorporation with PCL/PVP nanofibrous scaffolds is a potential therapeutic strategy for promoting bone healing by modulating M1 macrophages to a more M2 phenotype at early stages of postimplantation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available